Showing 21,161 - 21,180 results of 24,578 for search 'CZ12~', query time: 1.53s Refine Results
  1. 21161

    Frequencies and ethnic distribution of ABO and RhD blood groups in China: a population-based cross-sectional study by Min Liu, Jue Liu, Shikun Zhang, Qiaomei Wang, Haiping Shen, Yiping Zhang

    Published 2017-12-01
    “…We aimed to evaluate the distribution of ABO and RhD blood groups among Chinese ethnic groups.Design A population-based cross-sectional study.Setting Data on ABO groups and ethnicities were obtained from the National Free Preconception Health Examination Project (NFPHEP) with participants from 220 counties of 31 provinces in ChinaParticipants There were 3 832 034 participants aged 21–49 years who took part in the NFPHEP from January 2010 to December 2012 and were included in this study.Outcome Measures The proportion of ABO and RhD blood groups among different ethnic groups was calculated.Results ABO and RhD blood distribution was significantly different among nine ethnic groups (P<0.001). …”
    Get full text
    Article
  2. 21162

    Investigation of endurance of AMg6 alloy under cyclic volumetric thermal deformation by I. Yu. Lesnyak, Z. N. Sokolovsky, S. V. Gavrilenko

    Published 2022-11-01
    “…A comparative analysis of the calculated endurance of the experimental samples with the actual endurance of the structural material (hard worked alloy AMg6) of a real orbital object such as the «Zarya» module of the international space station shows a discrepancy of no more than 12,5 %.…”
    Get full text
    Article
  3. 21163
  4. 21164

    Emergency Medical Services Provider-Perceived Alzheimer’s Disease and Related Dementias in the Prehospital Setting by Esmeralda Melgoza, Valeria Cardenas, Hiram Beltrán-Sánchez

    Published 2024-11-01
    “…Results: A total of 55,129 patient encounters were recorded, with EMS provider-perceived ADRD recorded in 4,112 (7.5%). Among cases with EMS provider-perceived ADRD, the most common primary impressions were mental disorders (17.1%), weakness (17.0%), injury (15.7%), and pain (13.1%). …”
    Get full text
    Article
  5. 21165
  6. 21166
  7. 21167
  8. 21168
  9. 21169
  10. 21170
  11. 21171

    实时荧光定量PCR检测肾透明细胞癌hIRS-1和hIRS-2的表达及临床意义

    Published 2010-01-01
    “…【目的】 本研究检测hIRS-1 mRNA和hIRS-2 mRNA在肾透明细胞癌组织和对应癌旁正常组织中的表达,分析其与临床病理参数之间的关系,评价hIRS-1和hIRS-2的临床意义65377;【方法】 应用实时荧光定量PCR法对hIRS-1及hIRS-2基因在43例肾透明细胞癌组织和对应癌旁正常组织中的表达进行检测,分析其与临床病理指标的关系65377;【结果】 hIRS-1 mRNA在肾透明细胞癌和癌旁组织中均存在表达,hIRS-1基因在肾透明细胞癌组织和对应癌旁正常组织中比较无显著差异(0.612 ± 0.127 vs 0.645 ± 0.116,P > 0.05);而hIRS-2基因在肾透明细胞癌中存在高表达,hIRS-2基因在肾透明细胞癌组织和对应癌旁正常组织中比较有显著差异(1.016 ± 0.143 vs 0.792 ± 0.136,P < 0.05);hIRS-1 mRNA的表达与患者年龄65380;性别65380;肿瘤大小65380;病理分级及临床分期无关(P > 0.05);hIRS-2 mRNA的表达与肿瘤大小及临床分期有关(P < 0.05),与患者年龄65380;性别65380;及病理分级无关(P > 0.05)65377;【结论】 hIRS-1 mRNA在肾透明细胞癌和癌旁组织中均存在表达,两者比较差异无统计学意义;hIRS-2 mRNA在肾透明细胞癌中存在高表达,提示hIRS-2基因在肾透明细胞癌细胞癌变过程中可能发挥重要作用65377; 关键词: 肾透明细胞癌; 实时荧光定量PCR; 胰岛素受体底物…”
    Get full text
    Article
  12. 21172

    Metagenomic analysis of DNA viruses from posttransplant lymphoproliferative disorders by Vikas R. Dharnidharka, Marianna B. Ruzinova, Chun‐Cheng Chen, Priyanka Parameswaran, Harry O'Gorman, Charles W. Goss, Hongjie Gu, Gregory A. Storch, Kristine Wylie

    Published 2019-03-01
    “…In multivariable analyses, T cell PTLD (P = 0.006) and TTV PCR level (P = 0.012) remained significant. In EBV‐positive PTLD, EBNA‐LP, EBNA1 and EBNA3C had significantly higher levels of nonsynonymous gene variants compared to the other EBV genes. …”
    Get full text
    Article
  13. 21173
  14. 21174

    Differences in Physical and Psychological Parameters in Sub-Elite, Male, Youth Soccer Players with Jumper's Knee Following Physical Therapy Compared to Healthy Controls: A Longitud... by Marc Niering, Thomas Muehlbauer

    Published 2021-02-01
    “…Further, psychological parameters showed worse values in JK than in HC for the AMS Sport items "hope for success" and "fear of failure" that especially showed a significant difference at T1 (*d* = 0.65; *p* = 0.032 / *d* = 0.68; *p* = 0.027) and T2 (*d* = 0.50; *p* = 0.076 / *d* = 0.80; *p* = 0.012). Moreover, the JK group showed significantly higher incident rates for non-contact lower limb injuries (*d* = 0.69; *p* = 0.049) per 1,000 hours (i.e., practices/competitions), injury-related rest periods (*d* = 2.06; *p* = 0.043), and pain-related training interruptions (*d* = 1.35; *p* \< 0.001)…”
    Get full text
    Article
  15. 21175

    Intervenciones para prevenir la obesidad en los primeros 1000 días: revisión de alcance by Paola Alexandra Zepeda Ríos, Velia Margarita Cárdenas Villarreal, Danilo Castro Sifuentes, Milton Carlos Guevara Valtier

    Published 2024-09-01
    “…El análisis se centró en artículos publicados entre enero de 2012 y diciembre de 2022. Resultados: Se incluyeron 14 artículos que integraban 10 intervenciones. …”
    Get full text
    Article
  16. 21176
  17. 21177

    Enhancing fracture risk indication: The impact of bone load index and muscle fat infiltration on vertebral compression fracture by Xiao-Yue Jiang, Zhi-Yang Tang, Bo-Wen Liu, Si-Yuan Lu, Dong-Gang Pan, Hui Jiang, Xiu-Hong Shan

    Published 2025-01-01
    “…Correlation analysis demonstrated significant associations between BMD (r = −0.353, P = 0.002), BLI (r = 0.631, P < 0.001), PMFI (r = 0.412, P < 0.001), RPMFI (r = 0.513, P < 0.001), and the degree of vertebral compression. …”
    Get full text
    Article
  18. 21178
  19. 21179

    Significant Association between Serum Interleukin-6 and Helicobacter pylori Antibody Levels among H. pylori-Positive Japanese Adults by Hiroko Nakagawa, Takashi Tamura, Yoko Mitsuda, Yasuyuki Goto, Yoshikazu Kamiya, Takaaki Kondo, Kenji Wakai, Nobuyuki Hamajima

    Published 2013-01-01
    “…In multiple linear regression analysis adjusting for sex and age, the serum IL-6 level was still significantly associated with the IgG level in all subjects (β=0.18, P=0.012). Conclusion. Higher H. pylori IgG levels were significantly associated with higher serum IL-6 levels among H. pylori-infected individuals.…”
    Get full text
    Article
  20. 21180